Skip to content

Recruitment & Diversity

All CRIO Company News Running a Site Running a Study Recruitment & Diversity CRIO Culture
Improving patient diversity with technology
Recruitment & Diversity 3 Minute Read

Improving Patient Diversity in Clinical Trials with Technology

Improving patient diversity in clinical trials has been a major initiative by the FDA as evidenced by the 2020 Enhancing the Diversity of Clinical Trial Populations guidance as well as the 2022 Diversity Plans guidance. Many forward-thinking site operators are looking for new ways to access potential study participants that better reflect the population most likely...

Recruitment & Diversity
4 Minute Read -

CRIO Sites Have Twice the Average Patient Diversity

The new FDA guidance to enhance diversity in clinical research subjects has brought ethnic and racial diversity to the center stage for sponsors.  In this document, the FDA encourages sponsors to develop a Race and Ethnic Diversity Plan to incorporate into each protocol. More specifically, the FDA suggests that to achieve these diversity targets, sponsors...

Recruitment & Diversity
2 Minute Read -

CRIO Sites Out-enroll Non-CRIO Sites by 39%

Enrollment is critical to a trial, and site performance is a major – if not the most important – driver of that. We’ve always known that our full stack system enables sites to increase efficiency and enhance data quality, but do sites who use CRIO actually enroll more? We now have data to prove that...

Recruitment & Diversity
4 Minute Read -

Increasing Diversity in Clinical Trials – 3 Steps for Sponsors

Overview This past April, the FDA released updated guidance to sponsors and pharmaceutical companies on increasing racial and ethnic diversity in clinical trials to propel more inclusive research. Racial and ethnic minorities have historically been underrepresented in research,1 even within diseases where they make up the majority of those affected. The FDA also advises sponsors...

Recruitment & Diversity
1 Minute Read -

CRIO’s Patient Recruitment System is Now Gender Inclusive!

We know that clinical research changes are slow since it’s based on practices that require large, established data taxonomies. But at CRIO, we encourage pharma companies to adopt more gender-inclusive language. For example, some protocols may require only people assigned to one or the other sex at birth and if so, they should clearly state...

Get articles delivered to your inbox, every week